MAXONA has assembled a highly experienced and well recognized management team with a proven record of successfully developing and commercializing effective therapeutics.
Shawn Fatholahi
President & CEO
  • Commercial executive with record of success across a range of therapeutic areas including Neuroscience
  • Built and grew IMPAX Laboratories brand commercial business from one employee to 130 and $245 million in revenues  
Arthur Koch, Jr.
Chief Financial Officer
  • Prior CFO at IMPAX Laboratories, Strategic Diagnostics and IBAH
  • Experienced in all facets of financial operations of public and private companies including start-ups
Roy Freeman M.D.
Chief Medical Advisor
  • Professor of Neurology at Harvard Medical School
  • Authority on neuropathic pain, neuropathic pain clinical trial design, & peripheral nervous system disorders  
Bob Rappaport M.D.
Chief Regulatory Advisor
  • Prior FDA Division Director – Anesthesia, Analgesia, and Addiction Drug Products
  • Independent consultant on regulatory matters
Edward Allera J.D.
GC & Chief Legal Advisor
  • Partner at Buchanan, Ingersoll, & Rooney PC
  • Prior FDA Counsel - Recognized FDA regulatory expert